Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Policy
July 20, 2020 03:35 PM

Medicaid drug rule could have 340B, Medicare pay implications

Rachel Cohrs
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Modern Healthcare Illustration / Getty Images

    CMS' recent proposal to loosen Medicaid rules to facilitate value-based contracts for drugs could have wide-ranging implications for the 340B program, independent physicians' Medicare drug reimbursement, and patients' expenses.

    Drugmakers are concerned that CMS' new rule could lower the price they are allowed to charge hospitals in the 340B drug discount program. The Biotechnology Innovation Organization asked CMS to provide clarity on how part of the rule establishing multiple "best price" points for Medicaid rebates would apply to the 340B program.

    "Given the statutory calculation for ceiling price marrying components of the Medicaid rebate statute, the Best Price calculation of any individual product is critical," BIO wrote in comments on the proposal.

    Lower 340B prices could help hospitals, if drugmakers' worries come true. America's Essential Hospitals, a trade group for safety-net hospitals that is highly sensitive to 340B reimbursement changes, chose not to comment on the rule.

    However, providers who don't get 340B discounts are concerned that the rule could reduce how much they get paid for administering drugs. Independent oncology groups say that part of CMS' proposed rule could cause copay coupons to be counted toward Medicaid drug discounts. If that happened, it would lower provider pay for administering drugs, or cause drugmakers to change need-based discount programs for patients.

    A similar policy that would have included copay coupons in Average Sales Price calculations was included in a major drug-pricing package crafted by Senate Finance Committee Chair Chuck Grassley (R-Iowa) and ranking member Ron Wyden (D-Ore.). The package has stalled amid partisan bickering, but the Congressional Budget Office estimated that factoring coupons into ASP calculations would have saved the government $1.8 billion over 10 years.

    The Community Oncology Alliance pushed for changes to the Grassley-Wyden policy, including ensuring need-based copay assistance programs were exempted from the calculations.

    "We are most afraid of manufacturers being in an artificial situation. Rather than being at a competitive disadvantage with a market-distorted price, they may step back from these need-based assistance programs," COA Executive Director Ted Okon said.

    To avoid having their copay coupons counted toward Medicaid and ASP calculations, drugmakers would have to ensure the entire benefit of the coupons goes to the patient, instead of insurers or pharmacy benefit managers. Lindsay Bealor Greenleaf, vice president of policy at the healthcare consulting group ADVI Health, said that expectation is impractical.

    "This proposal would hurt physicians' bottom lines at a time when many practices are barely surviving during the pandemic," Greenleaf said.

    CMS said that copay coupons to patients are not currently included in Average Sales Price calculations.

    West Health Policy Center's Director of Health Policy Sean Dickson said if CMS' rule causes copay coupons to be counted toward Medicaid discounts, the implication would likely be much more significant for the 340B drug discount program, as the affected discounts would be averaged with other sales for Medicare Part B payments.

    The significance of the impact on Average Sales Price would be determined by how many outpatient drugs are currently used in health plans that limit how copay coupons can be applied to patients' deductibles.

    "It's a little tenuous to say this is going to have a significant impact on ASP," Dickson said.

    Drugmakers would likely have to redesign their patient assistance programs to comply with the new rule as written. Dickson said drugmakers could likely find a way to accommodate the rules through patient assistance charities or some other structure. But Texas Oncology Executive Vice President Dr. Debra Patt said she is concerned that patients could stop treatment courses if manufacturers choose to change their copay coupon programs and some patients get left behind.

    "With many patients, there are trade-offs they have to weigh that lead to noncompliance," Patt said.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    legal doctor
    FTC lawsuit isn't expected to slow roll-ups, lawyers say
    Biden signs organ transplant overhaul measure
    Biden signs organ transplant overhaul measure
    Most Popular
    1
    Centene to lay off 2,000 workers
    2
    How health systems are battling price-gouging allegations
    3
    Senate advances bill to temporarily aid hospitals, health centers
    4
    Elevance, Blue Cross Louisiana halt $2.5B proposed deal
    5
    Tower Health to sell urgent care centers, close others
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing